ArticleFrontiers in medicine2026
Vibroacoustic lung therapy and early postoperative oxygenation after cardiac surgery: a multicentre prospective study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative respiratory dysfunction remains a clinically significant problem after cardiac surgery. However, clinical evidence on vibroacoustic pulmonary therapy in adult cardiac surgery patients remains limited. The study aimed to compare early postoperative oxygenation following vibroacoustic pulmonary therapy using VibroLUNG with routine manual chest physiotherapy after cardiac surgery. Methods: This prospective, multicentre, observational, non-randomized comparative study included adult patients aged 18-80 years who underwent elective cardiac surgery and developed postoperative respiratory dysfunction meeting the study eligibility criteria. Group allocation reflected routine clinical practice and device availability at the participating centers. Patients received either vibroacoustic pulmonary therapy using VibroLUNG or routine manual percussion chest physiotherapy. The principal respiratory outcome analysed in this manuscript was the P/F ratio at the early postoperative assessment. Key secondary outcomes included FiO₂ requirement, SpO₂, PaO₂, PaCO₂, acid-base status parameters, clinical scales, radiographic findings, length of stay, and recorded safety outcomes. Results: Of 354 screened patients, 317 were included in the analysis: 156 in the VibroLUNG group and 161 in the control group. Baseline anthropometric characteristics were comparable; however, the distribution by center/region differed substantially between the groups. At the early postoperative assessment, the VibroLUNG group had a lower administered FiO₂ [35.0% [30.0-41.0] vs. 41.5% [40.0-50.0], Conclusion: VibroLUNG use was associated with a higher early postoperative P/F ratio and lower administered FiO₂. No adverse events, device deficiencies, or deaths were recorded during the study observation period. Causal inference is limited by the non-randomized design and centre-level differences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.